{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Random+Match&page=11", "query": { "intervention": "Random Match", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 5391, "total_pages": 540, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Random+Match&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Random+Match&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T00:58:40.237Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01232283", "title": "Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Apremilast", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Topical or Phototherapy Therapy", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 413, "start_date": "2010-11-22", "completion_date": "2016-11-30", "has_results": true, "last_update_posted_date": "2022-03-15", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Hot Springs, Arkansas • Bakersfield, California + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01232283" }, { "nct_id": "NCT01691846", "title": "A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus Type 2" ], "interventions": [ { "name": "aleglitazar+metformin", "type": "DRUG" }, { "name": "placebo+metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2012-10", "completion_date": "2013-09", "has_results": false, "last_update_posted_date": "2017-02-23", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 22, "location_summary": "Chino, California • Hawaiian Gardens, California • Los Angeles, California + 19 more", "locations": [ { "city": "Chino", "state": "California" }, { "city": "Hawaiian Gardens", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Thousand Oaks", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01691846" }, { "nct_id": "NCT00645788", "title": "Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "Ciprofloxacin (Cipro Inhale, BAYQ3939)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 288, "start_date": "2008-05", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 58, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 47 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00645788" }, { "nct_id": "NCT04572841", "title": "Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sjögren's Syndrome", "Sjogren's Syndrome" ], "interventions": [ { "name": "SAR441344", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 84, "start_date": "2020-11-12", "completion_date": "2024-02-09", "has_results": true, "last_update_posted_date": "2025-10-09", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 4, "location_summary": "DeBary, Florida • Duncansville, Pennsylvania • Memphis, Tennessee + 1 more", "locations": [ { "city": "DeBary", "state": "Florida" }, { "city": "Duncansville", "state": "Pennsylvania" }, { "city": "Memphis", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04572841" }, { "nct_id": "NCT00388297", "title": "Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Subclinical Hypothyroidism", "Hypothyroxinemia", "Pregnancy" ], "interventions": [ { "name": "Levothyroxine", "type": "DRUG" }, { "name": "Placebo for Levothyroxine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The George Washington University Biostatistics Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 1203, "start_date": "2006-10", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2019-02-21", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Chicago, Illinois • Detroit, Michigan + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" }, { "city": "New York", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00388297" }, { "nct_id": "NCT02546960", "title": "A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "ExPEC4V (4 : 4 : 4 : 4)", "type": "BIOLOGICAL" }, { "name": "ExPEC4V (4 : 4 : 4 : 8)", "type": "BIOLOGICAL" }, { "name": "ExPEC4V (8 : 8 : 8 : 8)", "type": "BIOLOGICAL" }, { "name": "ExPEC4V (8 : 8 : 8 : 16)", "type": "BIOLOGICAL" }, { "name": "ExPEC4V (16 : 16 : 16 : 16)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 848, "start_date": "2015-11-12", "completion_date": "2019-06-21", "has_results": false, "last_update_posted_date": "2020-04-22", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 17, "location_summary": "Mesa, Arizona • Hollywood, Florida • Leesburg, Florida + 14 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Leesburg", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Boise", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT02546960" }, { "nct_id": "NCT06237179", "title": "Behavioral Exercise Training to Reduce Cardiovascular Disease Risk", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Prostate Cancer", "Supportive Care" ], "interventions": [ { "name": "Exercise Training Intervention", "type": "BEHAVIORAL" }, { "name": "Healthy Living Education", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "MALE", "summary": "40 Years to 85 Years · Male only" }, "enrollment_count": 60, "start_date": "2024-02-21", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 2, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06237179" }, { "nct_id": "NCT01493596", "title": "A Safety, Tolerability and Pharmacokinetic Study of CPP-115", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cocaine Dependency" ], "interventions": [ { "name": "CPP-115", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Catalyst Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 55, "start_date": "2011-12", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2021-04-20", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01493596" }, { "nct_id": "NCT07221318", "title": "Evaluating a Mat-Based Biometric Vibration System for Sleep and Daily Recovery", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy Adult Male and Female Volunteers" ], "interventions": [ { "name": "Low-frequency whole-body vibration mat", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Florida International University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 50, "start_date": "2025-10-06", "completion_date": "2026-05", "has_results": false, "last_update_posted_date": "2025-10-27", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07221318" }, { "nct_id": "NCT03703882", "title": "Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Muscular Dystrophy, Duchenne" ], "interventions": [ { "name": "Edasalonexent", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Catabasis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "7 Years", "sex": "MALE", "summary": "4 Years to 7 Years · Male only" }, "enrollment_count": 131, "start_date": "2018-10-02", "completion_date": "2020-09-22", "has_results": true, "last_update_posted_date": "2022-06-21", "last_synced_at": "2026-10-25T00:58:40.237Z", "location_count": 24, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Sacramento, California + 20 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03703882" } ] }